Navigation Links
Report: Too Few Physicians, Nurses to Implement Presidential Candidates' Health Reform Plans
Date:1/25/2008

SAN DIEGO, Jan. 25 /PRNewswire/ -- Plans put forward by the leading 2008 presidential candidates to enhance access to healthcare will prove impractical without more physicians and nurses, a new report contends.

Titled, Physician and Nurse Supply: The Missing Piece of the Puzzle, the newly released report was completed by AMN Healthcare, the largest healthcare staffing company in the United States. The report reviews the healthcare reform proposals of seven leading presidential candidates and evaluates the proposals in the context of physician and nurse supply. According to the report, none of the candidates have yet proposed initiatives to increase physician and nurse supply to meet today's shortages, or to address the increased need for healthcare services that would arise under a reformed system featuring expanded access to care.

"There is a critical connection between access to healthcare and the supply of physicians, nurses and other medical professionals," notes Susan Nowakowski, President and Chief Executive Officer of AMN Healthcare. "The candidates are suggesting positive healthcare reforms, but to be effective, their plans should take into account the need for more doctors and nurses."

The report observes that the United States currently has a shortfall of 120,000 nurses. With the aging of the baby boomer population and an aging nurse workforce, that deficit is projected to be at least 350,000 by 2020, and, according to the U.S. Department of Health and Human Services, could reach 1,000,000 nurses by 2020. The report also cites the growing physician shortage, which is projected to reach between 85,000 and 200,000 physicians by 2020. Reforming the current healthcare system to cover some or all America's 47 million uninsured, as proposed by some candidates, would increase demand for healthcare services, exacerbating physician and nurse shortages, the report maintains.

In examining the leading presidential candidates' healthc
'/>"/>

SOURCE AMN Healthcare Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
2. New Report: Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest
3. New Report: Increasing Oregons Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
4. New report: private/public insurance mix is most practical way to achieve universal coverage
5. New Report: Increasing Marylands Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
6. Report: Medicare-Administered Drug Benefit Would be More Affordable, Comprehensive, Stable than Current Private Insurance-Run Drug Benefit
7. Landmark Report: Excess Body Fat Causes Cancer
8. New Report: Tobacco Regulation Would Save Iowa $449 Million in Health Care Costs by Preventing 25,700 Kids from Smoking
9. Nurses Send Sutter a Clear Message
10. Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention
11. New Director of Nursing Practice Named for Nurses Association
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 1GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 2GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 3GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 4GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 5GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 6nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 6632 1nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 6632 2MedQuist Integrates Search Engine from Primordial with SpeechQ 28TM 29 for Radiology 6630 1MedQuist Integrates Search Engine from Primordial with SpeechQ 28TM 29 for Radiology 6630 2